Transfer of shares to CEO
Transfer of shares to CEO
Medistim ASA has transferred 12,000 shares to Medistim CEO Kari E. Krogstad, at the last traded share price in 2021, of 367.50 NOK per share. This is in accordance with her compensation agreement with the company, as described in the Company's Annual Report. After the transfer, Kari E. Krogstad holds a total of 63,802 shares in the company and Medistim ASA holds 96,422 own shares.